Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567150295> ?p ?o ?g. }
- W2567150295 endingPage "10102" @default.
- W2567150295 startingPage "10091" @default.
- W2567150295 abstract "// Anna Bilotta 1 , Vincenzo Dattilo 2 , Sabrina D'Agostino 1 , Stefania Belviso 1 , Stefania Scalise 1 , Mariaconcetta Bilotta 1 , Eugenio Gaudio 1, 3 , Francesco Paduano 1, 4 , Nicola Perrotti 2 , Tullio Florio 5 , Alfredo Fusco 6 , Rodolfo Iuliano 1 , Francesco Trapasso 1 1 Department of Medicina Sperimentale e Clinica, University Magna Graecia of Catanzaro, Catanzaro, Italy 2 Department of Scienze della Salute, University Magna Graecia of Catanzaro, Catanzaro, Italy 3 Lymphoma and Genomics Research Program, Institute of Oncology Research (IOR), Bellinzona, Switzerland 4 Tecnologica Research Institute, Biomedical Section, Crotone, Italy 5 Laboratory of Pharmacology, Dept. of Internal Medicine, and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy 6 Istituto di Endocrinologia e Oncologia Sperimentale - CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, University Federico II of Napoli, Napoli, Italy Correspondence to: Rodolfo Iuliano, email: iuliano@unicz.it Francesco Trapasso, email: trapasso@unicz.it Keywords: protein tyrosine phosphatase, soluble isoform, angiogenesis, glioblastoma, angiogenic factor Received: September 20, 2016 Accepted: December 13, 2016 Published: December 29, 2016 ABSTRACT PTPRJ is a receptor protein tyrosine phosphatase with tumor suppressor activity. Very little is known about the role of PTPRJ ectodomain, although recently both physiological and synthetic PTPRJ ligands have been identified. A putative shorter spliced variant, coding for a 539 aa protein corresponding to the extracellular N-terminus of PTPRJ, is reported in several databases but, currently, no further information is available. Here, we confirmed that the PTPRJ short isoform (named sPTPRJ) is a soluble protein secreted into the supernatant of both endothelial and tumor cells. Like PTPRJ, also sPTPRJ undergoes post-translational modifications such as glycosylation, as assessed by sPTPRJ immunoprecipitation. To characterize its functional activity, we performed an endothelial cell tube formation assay and a wound healing assay on HUVEC cells overexpressing sPTPRJ and we found that sPTPRJ has a proangiogenic activity. We also showed that sPTPRJ expression down-regulates endothelial adhesion molecules, that is a hallmark of proangiogenic activity. Moreover, sPTPRJ mRNA levels in human high-grade glioma, one of the most angiogenic tumors, are higher in tumor samples compared to controls. Further studies will be helpful not only to clarify the way sPTPRJ works but also to supply clues to circumvent its activity in cancer therapy." @default.
- W2567150295 created "2017-01-06" @default.
- W2567150295 creator A5005937077 @default.
- W2567150295 creator A5007157411 @default.
- W2567150295 creator A5009214358 @default.
- W2567150295 creator A5023037220 @default.
- W2567150295 creator A5034123972 @default.
- W2567150295 creator A5035985266 @default.
- W2567150295 creator A5037075596 @default.
- W2567150295 creator A5043960607 @default.
- W2567150295 creator A5051245734 @default.
- W2567150295 creator A5051795556 @default.
- W2567150295 creator A5054461917 @default.
- W2567150295 creator A5059963876 @default.
- W2567150295 creator A5071416333 @default.
- W2567150295 date "2016-12-29" @default.
- W2567150295 modified "2023-09-26" @default.
- W2567150295 title "A novel splice variant of the protein tyrosine phosphatase<i>PTPRJ</i>that encodes for a soluble protein involved in angiogenesis" @default.
- W2567150295 cites W1182461782 @default.
- W2567150295 cites W1558546536 @default.
- W2567150295 cites W1560798071 @default.
- W2567150295 cites W1577577364 @default.
- W2567150295 cites W1602113572 @default.
- W2567150295 cites W1648237278 @default.
- W2567150295 cites W1752673633 @default.
- W2567150295 cites W1829321784 @default.
- W2567150295 cites W1901239216 @default.
- W2567150295 cites W1933900219 @default.
- W2567150295 cites W1966263926 @default.
- W2567150295 cites W1967890671 @default.
- W2567150295 cites W1976058749 @default.
- W2567150295 cites W1978041336 @default.
- W2567150295 cites W1986420486 @default.
- W2567150295 cites W1992776916 @default.
- W2567150295 cites W1999601388 @default.
- W2567150295 cites W2000179100 @default.
- W2567150295 cites W2000544335 @default.
- W2567150295 cites W2003870055 @default.
- W2567150295 cites W2007799501 @default.
- W2567150295 cites W2015323647 @default.
- W2567150295 cites W2028159558 @default.
- W2567150295 cites W2038647647 @default.
- W2567150295 cites W2040892290 @default.
- W2567150295 cites W2047276059 @default.
- W2567150295 cites W2047684340 @default.
- W2567150295 cites W2052110007 @default.
- W2567150295 cites W2061835175 @default.
- W2567150295 cites W2068904865 @default.
- W2567150295 cites W2070837467 @default.
- W2567150295 cites W2071006062 @default.
- W2567150295 cites W2077661851 @default.
- W2567150295 cites W2077689651 @default.
- W2567150295 cites W2089762123 @default.
- W2567150295 cites W2101756276 @default.
- W2567150295 cites W2106234246 @default.
- W2567150295 cites W2107784203 @default.
- W2567150295 cites W2113633302 @default.
- W2567150295 cites W2114157556 @default.
- W2567150295 cites W2116121003 @default.
- W2567150295 cites W2118008248 @default.
- W2567150295 cites W2129734511 @default.
- W2567150295 cites W2133029597 @default.
- W2567150295 cites W2139789198 @default.
- W2567150295 cites W2148286539 @default.
- W2567150295 cites W2153189745 @default.
- W2567150295 cites W2157433715 @default.
- W2567150295 cites W2236878792 @default.
- W2567150295 cites W2247653057 @default.
- W2567150295 cites W2345788031 @default.
- W2567150295 cites W2397883910 @default.
- W2567150295 cites W2417409579 @default.
- W2567150295 cites W2466126443 @default.
- W2567150295 cites W339304748 @default.
- W2567150295 cites W4233755960 @default.
- W2567150295 cites W2165547851 @default.
- W2567150295 doi "https://doi.org/10.18632/oncotarget.14350" @default.
- W2567150295 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5354644" @default.
- W2567150295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28052032" @default.
- W2567150295 hasPublicationYear "2016" @default.
- W2567150295 type Work @default.
- W2567150295 sameAs 2567150295 @default.
- W2567150295 citedByCount "6" @default.
- W2567150295 countsByYear W25671502952018 @default.
- W2567150295 countsByYear W25671502952019 @default.
- W2567150295 countsByYear W25671502952022 @default.
- W2567150295 crossrefType "journal-article" @default.
- W2567150295 hasAuthorship W2567150295A5005937077 @default.
- W2567150295 hasAuthorship W2567150295A5007157411 @default.
- W2567150295 hasAuthorship W2567150295A5009214358 @default.
- W2567150295 hasAuthorship W2567150295A5023037220 @default.
- W2567150295 hasAuthorship W2567150295A5034123972 @default.
- W2567150295 hasAuthorship W2567150295A5035985266 @default.
- W2567150295 hasAuthorship W2567150295A5037075596 @default.
- W2567150295 hasAuthorship W2567150295A5043960607 @default.
- W2567150295 hasAuthorship W2567150295A5051245734 @default.
- W2567150295 hasAuthorship W2567150295A5051795556 @default.
- W2567150295 hasAuthorship W2567150295A5054461917 @default.
- W2567150295 hasAuthorship W2567150295A5059963876 @default.